Apotex Launches Pre-Emptive Strike Against Par
A patent squabble has erupted between two generic drug makers, as Apotex Inc. has slapped Par Pharmaceuticals with a lawsuit in hopes of blocking the company from suing it over a...To view the full article, register now.
Already a subscriber? Click here to view full article